Symbol="FHTX"
AssetType="Common Stock"
Name="Foghorn TherapeuticsÂ Inc"
Description="Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs that target genetically determined dependencies within the chromatin regulatory system. The company is headquartered in Cambridge, Massachusetts."
CIK="1822462"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="405282000"
EBITDA="-122086000"
PERatio="None"
PEGRatio="None"
BookValue="-1.179"
DividendPerShare="0"
DividendYield="0"
EPS="-2.74"
RevenuePerShareTTM="0.52"
ProfitMargin="0"
OperatingMarginTTM="-5.78"
ReturnOnAssetsTTM="-0.197"
ReturnOnEquityTTM="-4.704"
RevenueTTM="21726000"
GrossProfitTTM="-86390000"
DilutedEPSTTM="-2.74"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.247"
AnalystTargetPrice="15.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.03"
PriceToBookRatio="10.71"
EVToRevenue="2.963"
EVToEBITDA="0.568"
Beta="2.215"
num_52WeekHigh="17.04"
num_52WeekLow="4.51"
num_50DayMovingAverage="8.3"
num_200DayMovingAverage="7.15"
SharesOutstanding="41824800"
DividendDate="None"
ExDividendDate="None"
symbol="FHTX"
open="9.43"
high="9.97"
low="9.41"
price="9.87"
volume="39528.00"
latest_trading_day="2023-08-15"
previous_close="9.44"
change="0.43"
change_percent="4.5551%"
aroon_positive_momentum_days="67"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="83023"
Change_recent_avg="0.05"
Delta_recent_avg="0.58"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="0.58"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="506"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0099.jpeg"
image_negative_thumbnail_id_2="1094"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="595"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_positive_thumbnail_id_1="620"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0088.jpeg"
image_positive_thumbnail_id_2="1016"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0178.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
